We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Diagnostic Kit Incorporates Lateral Flow Immunochromatographic Technique

By LabMedica International staff writers
Posted on 11 May 2010
A rapid diagnostic kit is based on the measurement of the total amount of cell-associated CD4 protein in whole blood samples such as a finger prick.

The methodology uses a simple lateral flow immunochromatographic technique incorporated into a rapid test kit design. More...
An instrument reader was designed for use with the CD4 test in laboratories and physician clinics. The reader is used to ensure a standardized approach in test-kit result interpretation.

The new test kit will be able to guide treatment decisions at the point of care (POC) without extensive training or sophisticated equipment. The reader will provide a level of automation and improved precision that will enhance uptake of the technology in the developed world, as well as a being a valuable tool for training in the developing world.

The use of rapid POC diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system, will be an important factor in improving the lives of people living with human immunodeficiency virus (HIV) and AIDS, especially in resource-poor countries.

The Burnet Institute (Melbourne, Australia) in collaboration with Rush University (Chicago, IL, USA) and Duke University (Durham, NC, USA) developed the new rapid diagnostic kit. Early clinical trials of the CD4 kit currently in progress are showing promising results and the cost of the kit is estimated to be less than US$1.80 when commercially available.

Burnet Institute's Associate Prof. David Anderson said point-of-care tests that are cheap, easy to use, and reliable, and able to be read visually in the field meant that patients would receive access to antiretroviral drugs faster and have an improved quality of life. He added, "This style of rapid point-of-care tests have become valuable tools in infectious disease diagnostics and are especially useful for diagnosis of diseases such as HIV, hepatitis B, and syphilis, as well as containing outbreaks of rapidly spreading diseases, for example hepatitis E,"

Prof. Anderson spoke on global diagnostics at the Bio2010 International Convention in Chicago, (IL, USA), which took place from May3-6, 2010.

Related Links:
Burnet Institute
Rush University
Duke University


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.